Published in Pain Res Manag on September 15, 2015
NMDA glutamate receptor antagonism and the heritable risk for alcoholism: new insights from a study of nitrous oxide. Int J Neuropsychopharmacol (2017) 0.75
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain (1988) 15.15
Persistent postsurgical pain: risk factors and prevention. Lancet (2006) 8.46
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol (2010) 4.55
The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial. Lancet (2014) 3.70
Can we conquer pain? Nat Neurosci (2002) 2.56
Mechanisms of disease: neuropathic pain--a clinical perspective. Nat Clin Pract Neurol (2006) 2.44
Influence of nitrous oxide anesthesia, B-vitamins, and MTHFR gene polymorphisms on perioperative cardiac events: the vitamins in nitrous oxide (VINO) randomized trial. Anesthesiology (2013) 2.39
Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology (2008) 2.29
Transition from acute to chronic postsurgical pain: risk factors and protective factors. Expert Rev Neurother (2009) 2.14
Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther (2002) 2.12
Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial. Anesth Analg (2010) 1.62
Nitrous oxide and serious morbidity and mortality in the POISE trial. Anesth Analg (2013) 1.50
Gabapentin acts within the locus coeruleus to alleviate neuropathic pain. Anesthesiology (2008) 1.48
Analgesic treatment with pregabalin does not prevent persistent pain after peripheral nerve injury in the rat. Pain (2013) 1.43
Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem (2005) 1.30
Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology (2007) 1.27
The neuropathic component in persistent postsurgical pain: a systematic literature review. Pain (2013) 1.27
Effect of N-methyl-D-aspartate receptor epsilon1 subunit gene disruption of the action of general anesthetic drugs in mice. Anesthesiology (2005) 1.22
The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain (2001) 1.22
Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther (1999) 1.19
Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain (2007) 1.19
NMDA antagonists and neuropathic pain--multiple drug targets and multiple uses. Curr Pharm Des (2005) 1.16
Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. Br J Pharmacol (2005) 1.11
Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat. Pain (1987) 1.09
Nitrous oxide (N(2)O) requires the N-methyl-D-aspartate receptor for its action in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2004) 1.06
Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother (2010) 1.05
Prolonged exposure to inhalational anesthetic nitrous oxide kills neurons in adult rat brain. Neuroscience (2003) 1.04
Use of gabapentin for perioperative pain control -- a meta-analysis. Pain Res Manag (2007) 1.03
The minimum alveolar concentration of nitrous oxide in man. Anesth Analg (1982) 1.01
Chronic postsurgical pain after nitrous oxide anesthesia. Pain (2011) 1.01
Differential effects of general anesthetics on G protein-coupled inwardly rectifying and other potassium channels. Anesthesiology (2001) 0.99
Nitrous oxide minimum alveolar anesthetic concentration in rats is greater than previously reported. Anesth Analg (1994) 0.97
Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil. Anesthesiology (2007) 0.95
Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol (2002) 0.95
Nitrous oxide: are we still in equipoise? A qualitative review of current controversies. Br J Anaesth (2013) 0.95
NMDA receptor antagonists for the treatment of neuropathic pain. Pain Med (2010) 0.95
Advances in understanding the actions of nitrous oxide. Anesth Prog (2007) 0.94
The two-pore-domain K(+) channels TREK-1 and TASK-3 are differentially modulated by copper and zinc. Mol Pharmacol (2004) 0.93
Prevention of chronic postoperative pain: cellular, molecular, and clinical insights for mechanism-based treatment approaches. Prog Neurobiol (2013) 0.92
Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists. Curr Top Med Chem (2006) 0.92
Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat. Brain Res (2010) 0.90
Gabapentin in acute postoperative pain management. Biomed Res Int (2014) 0.87
Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects. Brain Res (1998) 0.86
Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain. Anesthesiology (2011) 0.84
Successful management of postoperative pain with pregabalin after thoracotomy. Surg Today (2013) 0.84
Chronic pain after childbirth. Int J Obstet Anesth (2013) 0.83
Nitrous oxide revisited: evidence for potent antihyperalgesic properties. Anesthesiology (2005) 0.82
Nitrous oxide inhibits glutamatergic transmission in spinal dorsal horn neurons. Pain (2007) 0.80
Nitrous oxide (N2O) pre- and postsynaptically attenuates NMDA receptor-mediated neurotransmission in the amygdala. Neuropharmacology (2006) 0.79
Gabapentinoids are effective in decreasing neuropathic pain and other secondary outcomes after spinal cord injury: a meta-analysis. Arch Phys Med Rehabil (2014) 0.79
Sister chromatid exchange in human lymphocytes exposed to isoflurane and nitrous oxide in vitro. Br J Anaesth (1999) 0.77
A single nitrous oxide (N2O) exposure leads to persistent alleviation of neuropathic pain in rats. J Pain (2009) 0.77
Nitrous oxide and perioperative outcomes. J Anesth (2013) 0.76
The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg (2002) 1.22
RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci U S A (2006) 1.19
Supplementing desflurane-remifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements. Anesth Analg (2002) 1.19
Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology (2002) 1.09
Non-nociceptive environmental stress induces hyperalgesia, not analgesia, in pain and opioid-experienced rats. Neuropsychopharmacology (2007) 1.09
Long-term pain vulnerability after surgery in rats: prevention by nefopam, an analgesic with antihyperalgesic properties. Anesth Analg (2009) 0.99
Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats. Anesthesiology (2005) 0.95
The transcriptome of Nrf2-/- mice provides evidence for impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes. Toxicol Sci (2010) 0.93
Endogenous opioids released during non-nociceptive environmental stress induce latent pain sensitization Via a NMDA-dependent process. J Pain (2011) 0.92
Antiapoptotic activity of argon and xenon. Cell Cycle (2013) 0.91
Preemptive antihyperalgesia to improve preemptive analgesia. Anesthesiology (2008) 0.91
Isolation, characterization, and distribution of a novel neuropeptide, Rana RFamide (R-RFa), in the brain of the European green frog Rana esculenta. J Comp Neurol (2002) 0.90
Polyamine deficient diet to relieve pain hypersensitivity. Pain (2007) 0.90
Prevention of fentanyl-induced delayed pronociceptive effects in mice lacking the protein kinase Cgamma gene. Neuropharmacology (2004) 0.88
Nitrous oxide (N2O) prevents latent pain sensitization and long-term anxiety-like behavior in pain and opioid-experienced rats. Neuropharmacology (2007) 0.85
Opioids: from analgesia to anti-hyperalgesia? Pain (2005) 0.84
Tonic and phasic effects of corticosterone on food restriction-induced hyperactivity in rats. Psychoneuroendocrinology (2008) 0.83
Nitrous oxide revisited: evidence for potent antihyperalgesic properties. Anesthesiology (2005) 0.82
Structure and functions of the novel hypothalamic RFamide neuropeptides R-RFa and 26RFa in vertebrates. Peptides (2006) 0.82
Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats. Can J Anaesth (2008) 0.80
Acute tolerance to opioids: methodological, theoretical and clinical implications. Pain (2009) 0.79
Xenon prevents inflammation-induced delayed pain hypersensitivity in rats. Neuroreport (2010) 0.77
Exogenous and endogenous opioid-induced pain hypersensitivity in different rat strains. Pain Res Manag (2014) 0.77
Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma. Eur J Pediatr (2003) 0.77
A single nitrous oxide (N2O) exposure leads to persistent alleviation of neuropathic pain in rats. J Pain (2009) 0.77
A high-dose of fentanyl induced delayed anxiety-like behavior in rats. Prevention by a NMDA receptor antagonist and nitrous oxide (N(2)O). Pharmacol Biochem Behav (2012) 0.77
Food, pain, and drugs: does it matter what pain patients eat? Pain (2012) 0.77
The effects of xenon and nitrous oxide gases on alcohol relapse. Alcohol Clin Exp Res (2013) 0.77
Delayed aversive effects of high-dose fentanyl. Prevention by a polyamine-deficient diet. Behav Brain Res (2008) 0.77
Sciatic nerve block fails in preventing the development of late stress-induced hyperalgesia when high-dose fentanyl is administered perioperatively in rats. Reg Anesth Pain Med (2012) 0.76
Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors. Bioorg Med Chem Lett (2012) 0.76
A polyamine-deficient diet opposes hyperalgesia, tolerance and the increased anxiety-like behaviour associated with heroin withdrawal in rats. Pharmacol Biochem Behav (2012) 0.75
[RF9, a powerful and selective antagonist of the neuropeptide FF receptors, prevents the development of the tolerance to opioids]. Med Sci (Paris) (2006) 0.75
Phasing-in plasma metanephrines determination. Eur J Endocrinol (2013) 0.75